1Hink GW. Introduction of eyclooxygenase-2 by interleukin-1 alpha evidence for posttranseripfional regulation[J]. J Biol Chem, 2004, 269 ( 11 ) : 769-775.
2Mu YC, Tsai MC. Nentrephil elastase stimulates human airway epithelial cell to produce PGE2 through activation of p44/42MAPK and up- regulation of eycooxygenase-2[ J]. Am J Physiol Lung Cell Mol Physiol, 2007, 285(4) : 925-930.
3Feng-Qi Zhao and Aileen F Keafing. Function properties and genomics of glucose transporters [ J ]. Curr Genomics, 2007, 8 (2) : 113 -128.
10Kim YM, Park YK, Yan JY, et al. Expression of the GLUT glucose transporterlng all bladder carcinomas [ J ]. Gastroenterel Hepatol, 2002, 49(46) : 907-911.
6Ozbudak IH, Karaveli S, Simsek T, et al . Neoangiogenesis and expression of hypoxia-inducible factor lalpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas. Gynecol Oncol, 2008, 108 (3) :603-608.
7Ashton-Saqer A, Paulino AF, Afifv AM. GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adeno-carcinoma. Appl Immunohistochem Mol Morphol, 2006, 14 (2) :187- 192.
8Goldman NA, Katz EB, Glenn AS, et al. GLUT1 and GLUTS in en-dometrium and endometrial adenocarcinoma. Mod Pathol, 2006, 19 ( 11 ) : 1429-1436.
9Alatas F,Alatas O,Metintas M,et al.Diagnostic value of CEA,CA 15-3,CA 19-9,CYFRA 21-1,NSE and TSA assay in pleural effusions [J]. Lung Cancer,2001,31( 1 ) :9-16.
10Porcel JM, Vires M, Esquerda A, et al.Use of a panel of tumor mark- (carcinoembryonic antigen,cancer antigen 125,carbohydrate antigenl5-3,and cytokeratin 19 fragments)in pleural fluid for the differential diagnosis of benign and malignant effusions [J ].Chest, 2004,126(6): 1757-1763.
2Thapar M, Mishra R K, Sharma A, et al. Critical analysis of cell block versus smear examination in effusions [ J ]. J Cytol, 2009, 26 (2) : 60 -64.
3Swiderek J, Morcos S, Donthireddy V, et al. Prospective study to de- termine the volume of pleural fluid required to diagnose maliguancy [J]. Chest, 2010, 137(1): 68-73.
4Terry J, Leung S, Laskin J, et al. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples[ J]. Am J Surg Pathol, 2010, 34 (12) : 1805 -1811.
5Kim D H, Kwon M S. Role of fine needle aspiration cytology, cell block preparation and CD63, 1:63 and CD56 immunostaining in classif- ying the specific tumor type of the lung[J]. Acta Cytol, 2010, 54 (1) : 55 -59.
6Noda Y, Fujita N, Kobayashi G, et al. Diagnostic efficacy of the cell block method in comparison with smear cytology of tissue samples ob- tained by endoscopic ultrasound-guided fine-needle aspiration [ J ]. J Gastroenterol, 2010, 45 (8) : 868 - 875.
9Hino R,Uozaki H,Inoue Y. Survival advantage of EBV-associated gastric carcinoma:survivin up-regulation by viral latent membrane protein 2A[J].Cancer Research,2008,(05):1427-1435.
10Ambresini G,Adida C,Altiefi DC. A novel anti-apoptesis gene,survivin,expressed in cancer and lymphoma[J].Nature Medicine,1997,(08):917-921.
